Identification of a Potent and Selective Pharmacophore for Cdc25 Dual Specificity Phosphatase Inhibitors.-Reference-Cited by-同舟云学术

Identification of a Potent and Selective Pharmacophore for Cdc25 Dual Specificity Phosphatase Inhibitors.

Published:2002-04-01 Issue:4 Volume:61 Page:720-728
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Lazo John S.,Nemoto Kaoru,Pestell Katharine E.,Cooley Kathleen,Southwick Eileen C.,Mitchell Douglas A.,Furey William,Gussio Rick,Zaharevitz Daniel W.,Joo Beomjun,Wipf Peter

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference35 articles.

1. Role of the Cdc25A phosphatase in human breast cancer

2. RIBBONS 2.0

3. Dual-Specific Cdc25B Phosphatase: In Search of the Catalytic Acid

4. Form and Function in Protein Dephosphorylation

5. The Cell Cycle Cdc25A Tyrosine Phosphatase Is Activated in Degenerating Postmitotic Neurons in Alzheimer's Disease

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-throughput screening identifies MCM chromatin loading inhibitors targeting cells with increased replication origins;iScience;2024-08

2. Phosphoproteomic investigation of targets of protein phosphatases in EGFR signaling;Scientific Reports;2024-04-04

3. Phosphoproteomic investigation of targets of protein phosphatases in EGFR signaling;2024-02-16

4. Phosphoproteomic investigation of targets of protein phosphatases in EGFR signaling;2024-02-05

5. Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine;Frontiers in Pharmacology;2024-01-19